Literature DB >> 32332045

Ovoid palatal patch: a clue to anti-TIF1γ dermatomyositis.

Ellen Franciosi1, Kaitlin Blankenship1, Laura Houk1, Mehdi Rashighi2,3.   

Abstract

An 80-year-old woman presented with a several-year history of progressive hair loss and scalp pruritus. No other rashes or muscle weakness were noted on examination. Scalp biopsy showed interface dermatitis, dense perivascular and periadnexal lymphocytic infiltrate, mucin and scarring alopecia. Laboratory analysis did not show evidence of myositis. The patient was started on hydroxychloroquine for possible cutaneous lupus erythematosus. On follow-up, she presented with a new violaceous rash on the superior eyelids and a well-defined oval patch on the mid-hard palate suspicious for dermatomyositis. Myositis-specific autoantibodies revealed presence of anti-transcriptional intermediary factor-1γ (anti-TIF1γ) in the serum. Anti-TIF1γ autoantibody-positive dermatomyositis is a newly recognised subtype of dermatomyositis that is highly associated with amyopathic disease and has an increased risk of malignancy, making prompt diagnosis crucial. This case highlights the utility of a thorough oral exam in patients suspected to have connective tissue disease as the distinctive ovoid palatal patch is nearly pathognomonic for anti-TIF1γ dermatomyositis. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  connective tissue disease; dermatology

Mesh:

Substances:

Year:  2020        PMID: 32332045      PMCID: PMC7202738          DOI: 10.1136/bcr-2019-234111

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis.

Authors:  Paul M Hoesly; Jason C Sluzevich; Anokhi Jambusaria-Pahlajani; Elizabeth R Lesser; Michael G Heckman; Andy Abril
Journal:  J Am Acad Dermatol       Date:  2018-11-17       Impact factor: 11.527

2.  Ovoid Palatal Patch: An Ominous Sign in Dermatomyositis.

Authors:  Rajsmita Bhattacharjee; Keshavamurthy Vinay
Journal:  J Clin Rheumatol       Date:  2020-06       Impact factor: 3.517

Review 3.  Amyopathic Dermatomyositis: A Concise Review of Clinical Manifestations and Associated Malignancies.

Authors:  Jeremy Udkoff; Philip R Cohen
Journal:  Am J Clin Dermatol       Date:  2016-10       Impact factor: 7.403

4.  Ovoid Palatal Patch in Dermatomyositis: A Novel Finding Associated With Anti-TIF1γ (p155) Antibodies.

Authors:  Laura L Bernet; Matthew A Lewis; Kerri E Rieger; Livia Casciola-Rosen; David F Fiorentino
Journal:  JAMA Dermatol       Date:  2016-09-01       Impact factor: 10.282

Review 5.  The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum.

Authors:  Elizabeth Ghazi; Richard D Sontheimer; Victoria P Werth
Journal:  Clin Exp Rheumatol       Date:  2012-11-22       Impact factor: 4.473

6.  Strong correlation between cancer progression and anti-transcription intermediary factor 1γ antibodies in dermatomyositis patients.

Authors:  Mariko Ogawa-Momohara; Yoshinao Muro; Teruyuki Mitsuma; Masao Katayama; Koichi Yanaba; Mizuho Nara; Masao Kakeda; Michihiro Kono; Masashi Akiyama
Journal:  Clin Exp Rheumatol       Date:  2018-05-08       Impact factor: 4.473

  6 in total
  1 in total

Review 1.  Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis.

Authors:  Rochelle L Castillo; Alisa N Femia
Journal:  Ann Transl Med       Date:  2021-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.